جهت دسترسی به کاربرگه ی زیر، از این لینک استفاده کنید.
|Title:||Polytetrafluoroethylene-covered retrievable expandable nitinol stents for malignant esophageal obstructions: factors influencing the outcome of 270 patients.|
|Authors:||Park, Jung-Hoon;Song, Ho-Young;Kim, Jin Hyoung;Jung, Hwoon-Yong;Kim, Jong-Hoon;Kim, Sung-Bae;Lee, Heuiran|
|Keywords:||Alloys;Coated Materials, Biocompatible;Combined Modality Therapy;Device Removal;Esophageal Neoplasms;Esophageal Neoplasms: pathology;Esophageal Neoplasms: therapy;Esophageal Stenosis;Esophageal Stenosis: pathology;Esophageal Stenosis: therapy;Female;Fluor|
|Abstract:||OBJECTIVE: The purpose of this study was to evaluate the clinical effectiveness of polytetrafluoroethylene (PTFE)-covered retrievable expandable nitinol stents in patients with malignant esophageal strictures and to identify prognostic factors associated with clinical outcomes.\n\nMATERIALS AND METHODS: From 2001 to 2010, 320 PTFE-covered stents were placed in 270 patients. Technical and clinical success, complications, survival, and stent patency were measures of clinical effectiveness. The relationships among complications and age, sex, stricture location, stricture length, chemotherapy alone, chemoradiotherapy, and malignancy source were examined. Independent prognostic factors of overall survival and stent patency were identified.\n\nRESULTS: Stent placement and removal were technically successful and tolerated without procedural complications, and 98% of patients achieved clinical success. The complication rate was 30%. Two removed stents exhibited covering membrane separation. Chemotherapy was associated with increased stent migration (p = 0.002). Stricture location and chemoradiotherapy were associated with esophagorespiratory fistula development (p = 0.033 and p < 0.001, respectively). Median and mean survival periods were 114 days (95% CI, 102-126 days) and 166 days (138-193 days). Chemotherapy and chemoradiotherapy were independent prognostic factors for survival (p = 0.050 and p = 0.032, respectively). The median and mean stent patency periods were 60 days (41-79 days) and 90 days (71-108 days). Chemoradiotherapy was the only independent prognostic factor for stent patency (p = 0.012).\n\nCONCLUSION: The PTFE-covered stents were clinically effective. Membrane degradation was not evident, although 0.7% of the patients experienced covering membrane separation. Chemotherapy was associated with increased migration and prolonged survival. Chemoradiotherapy was associated with increased esophagorespiratory fistula formation and decreased stent patency.|
|More Information:||VOLUME : 199ISSUE : 6START PAGE : 1380|
END PAGES : 6
|Appears in Collections:||American Journal of Roentgenology|
Files in This Item:
|2012medicine article ab (383).pdf||775.38 kB||Adobe PDF|
Download Request a copy
تمامی کاربرگه ها در کتابخانه ی دیجیتال حنان به صورت کامل محافظت می شوند.